Ausgabe 2/2020
Inhalt (26 Artikel)
Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?
Kristen D. Whitaker, Deepa Sheth, Olufunmilayo I. Olopade
Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound
Aubriana M. McEvoy, Steven Poplack, Katelin Nickel, Margaret A. Olsen, Foluso Ademuyiwa, Imran Zoberi, Elizabeth Odom, Jennifer Yu, Su-Hsin Chang, William E. Gillanders
Spatial location of local recurrences after mastectomy: a systematic review
Orit Kaidar-Person, Philip Poortmans, Birgitte Vrou Offersen, Sabine Siesling, Miri Sklair-Levy, Icro Meattini, Dirk de Ruysscher, Thorsten Kühn, Liesbeth J. Boersma
TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin
Huayan Ren, Xiaoyi Mi, Pengyuan Zhao, Xueyan Zhao, Na Wei, Huifen Huang, Zhongqin Meng, Junna Kou, Mingfang Sun, Yuqiong Liu, Hongyan Zhang, Jianping Yang, Wencai Li, Huixiang Li
Patient preferences for locoregional therapy in early-stage breast cancer
Christina A. Minami, Tari A. King, Elizabeth A. Mittendorf
Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
Albina Stocker, Andreas Trojan, Constanze Elfgen, Marie-Louis Hilbers, Linda Moskovszky, Zsuzsanna Varga
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
Kai Li, Ning Liao, Bo Chen, Guochun Zhang, Yulei Wang, Liping Guo, Guangnan Wei, Minghan Jia, Lingzhu Wen, Chongyang Ren, Li Cao, Hsiaopei Mok, Cheukfai Li, Jiali Lin, Xiaoqing Chen, Zhou Zhang, Ting Hou, Min Li, Jing Liu, Charles M. Balch, Ning Liao
CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ
Marina A. Guvakova, Indira Prabakaran, Zhengdong Wu, Daniel I. Hoffman, Ye Huang, Julia Tchou, Paul J. Zhang
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
C. Criscitiello, A. Vingiani, P. Maisonneuve, G. Viale, G. Viale, G. Curigliano
Clinical decision trees support systematic evaluation of multidisciplinary team recommendations
Mathijs P. Hendriks, Xander A. A. M. Verbeek, Jeannette G. van Manen, Sannah E. van der Heijden, Shirley H. L. Go, Gea A. Gooiker, Thijs van Vegchel, Sabine Siesling, Agnes Jager
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients
Adrienne E. Borrie, Finnley A. Rose, Yun-Hee Choi, Francisco E. Perera, Nancy Read, Tracy Sexton, Michael Lock, Theodore A. Vandenberg, Karin Hahn, Jawaid Younus, Diane Logan, Kylea Potvin, Brian Yaremko, Edward Yu, John Lenehan, Stephen Welch, Wendy A. Teft, Richard B. Kim
External validation and modification of nomogram for predicting positive resection margins before breast conserving surgery
Ji-Jung Jung, Eunyoung Kang, Eun-Kyu Kim, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Hee-Chul Shin
Assessing preferences for receiving supportive care resources among patients seen at a Breast Care Center
Emily C. Wong, Celia P. Kaplan, Mikela Barulich, Michelle Melisko
Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation
Shagun Misra, Grace Lee, Yasmin Korzets, Lisa Wang, Anthea Lau, Christine Anne Koch, Jennifer Croke, Joelle Helou
The shape of breast cancer
Brook K. Byrd, Venkataramanan Krishnaswamy, Jiang Gui, Timothy Rooney, Rebecca Zuurbier, Kari Rosenkranz, Keith Paulsen, Richard J. Barth Jr
Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer
Bahar Moftakhar, Manidhar Lekkala, Myla Strawderman, Tae C. Smith, Philip Meacham, Bryan Fitzgerald, Carla I. Falkson, Ajay Dhakal
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
Richard S. Finn, Katalin Boer, Igor Bondarenko, Ravindranath Patel, Tamas Pinter, Marcus Schmidt, Yaroslav V. Shparyk, Anu Thummala, Nataliia Voitko, Eustratios Bananis, Lynn McRoy, Keith Wilner, Xin Huang, Sindy Kim, Dennis J. Slamon, Johannes Ettl
Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database
Zhong-Li Du, Yang Wang, Ding-Yuan Wang, Li Zhang, Zhi-Min Bian, Ying Deng, Cheng-Shan Xu, Dong-Cai Lin, Li Xie, Yao Jia, Ji-Dong Gao, Bai-Lin Zhang
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Milena Sant, Elisabetta Meneghini, Joana Bastos, Paolo Giorgi Rossi, Marcela Guevara, Kaire Innos, Alexander Katalinic, Leire Gil Majuelo, Rafael Marcos-Gragera, Florence Molinié, Elisabetta Rapiti, Ana Vizcaino, Vesna Zadnik, Pamela Minicozzi, L. Van Eycken, K. Henau, K. Innos, M. Mägi, F. Binder-Foucard, M. Velten, A. V. Guizard, P. Arveux, A. S. Woronoff, B. Amadeo, G. Coureau, E. Marrer, S. Boyer, N. Léone, B. Trétarre, M. Colonna, P. Delafosse, V. Démaret, K. Ligier, S. Ayrault-Piault, S. Bara, G. Defossez, B. Lapotre-Ledoux, L. Daubisse-Marliac, P. Grosclaude, A. Cowppli-Bony, F Molinié, V. Babaev, A. Katalinic, C. Amati, P. Baili, S. Bonfarnuzzo, E. Meneghini, P. Minicozzi, G. Moretti, M. Sant, Silvia Iacovacci, Susanna Busco, E. Marani, C. Casella, G. Carrozzi, C. Cirilli, R. Amodio, R. Cusimano, C. Nicita, R. Tumino, F. Ferrari, L. Mangone, F. Stracci, F. Bianconi, P. Contiero, G. Tagliabue, L. Molong, J. Rachtan, J. Janowski, A. Kubiak, S. Góźdź, P. Macek, M. Bielska-Lasota, J. Błaszczyk, K. Kępska, J. Bastos, B. Carrito, M. J. Bento, C. Castro, A. Mayer-da-Silva, A. Miranda, V. Zadnig, G. Plavc, L. Gil Majuelo, N. Larrañaga, C. Sabater, A. Torella, R. Marcos-Gragera, M. Puigdemont, E. Molina-Portillo, M. J. Sánchez-Pérez, E. Ardanaz, M. Guevara, J. Galceran, F. Saladié, C. Bouchardy, E. Fournier
“Are changes in breast density during the menstrual cycle relevant? To what?”
Jean L. Browne, Natalie Korsun, Lilian Casas, Ignacio Rodriguez, Beatriz Valero, Andreina Rincon, M. Angela Pascual
Racial differences in the relationship between surgical choice and subsequent patient-reported satisfaction outcomes among women with early-stage hormone-positive breast cancer
Prudvi Arabandi, Alexander N. Slade, Arnethea L. Sutton, Kandace P. McGuire, Vanessa Sheppard
Obesity and related conditions and risk of inflammatory breast cancer: a nested case–control study
Catherine Schairer, Cecile A. Laurent, Lisa M. Moy, Gretchen L. Gierach, Neil E. Caporaso, Ruth M. Pfeiffer, Lawrence H. Kushi
Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials
Kyaw Zin Thein, Thura Win Htut, Somedeb Ball, Sriman Swarup, Anita Sultan, Thein Hlaing Oo
Variation in pathological complete response in HER2-positive breast cancers with intrinsic subtypes assessed by PAM50 testing: secondary analysis from NSABP B-41 trial
Arun Kumar Goel, Vaishali Zamre, Shreebha Hari
Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
Blanche P. Alter, Ana F. Best
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
Ahrong Ham, Min Hwan Kim, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joohyuk Sohn